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Background: Periodontitis is a multi-factorial disease and several risk-factors such as infections, inflammatory
responses, oral hygiene, smoke, aging and individual predisposition are involved in the disease. Pathogens trigger
chronic inflammation with cytokines release which in turn leads to the destruction of the connective and the teeth
supporting bone. The identification of genetic factors controlling oral inflammation may increase our understanding
of genetic predisposition to periodontitis.
Single nucleotide polymorphisms in the promoter region of Vascular Endothelial Growth Factor, Alpha-1-Antichymotripsin,
hydroxy-methyl-glutaryl CoA reductase, Interferon alpha, Interleukin-1 Beta, Interleukin 10, Interleukin 6 and
Tumor Necrosis Factor- alpha genes from a case/control study were investigated.
Results: The C allele of Vascular Endothelial Growth Factor, A allele of Interleukin 10 and GG genotype of Tumor
Necrosis Factor-α were individually associated with chronic periodontitis. However, the concomitant presence of
the three genetic markers in the same subjects appeared to play a synergistic role and increased several folds
the risk of the disease.
Conclusions: Our findings offer new tools to implement the screening of unaffected subjects with an increased
susceptibility of periodontitis and increase our understanding regarding the genetic inflammatory background
related to familiarity of the disease.
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Periodontitis is a multi-factorial disease and several risk-
components, such as environmental, metabolic, genetic,
microbial factors, aging and poor oral hygiene status are
involved in the pathogenesis of the disease [1].
Colonization of endogenous gram-negative periodontal
bacteria including Porphyromonas gingivalis, Aggregatibacter
(Actinobacillus) actinomycetemcomitans,Tannerella forsythia
(forsythensis) and Treponema denticola appears to be the
primary initiator of disease [2] and activator of abnormal
chronic inflammation. It has been initially suggested that
susceptibility to periodontitis could be genetically deter-
mined by the immune responsiveness to bacterial lipopoly-
saccharides [3]. However, since LPS is not the only bacterial
products involved in periodontal inflammation, the genetic* Correspondence: manuela.ianni@libero.it
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reproduction in any medium, provided the orbackground of susceptibility to periodontitis remains largely
to be determined.
Moreover, a variable degree of decline in the immune
system efficiency is associated with aging and leads to an
increased susceptibility of infections in the elderly. The
periodontal apparatus is more vulnerable to destruction
in aged individuals and immune senescence may con-
tribute to periodontal disease of elderly [4].
Chronic inflammation and cytokines have been sug-
gested to play a pivotal role in destructive processes oc-
curring in periodontitis [5]. On the other hand, chronic
periodontitis is associated with systemic disease where
altered control of inflammation may play a role. In par-
ticular, chronic periodontitis may slightly influence the
risk of cardiovascular disease, respiratory infections, ad-
verse pregnancy outcome, rheumatoid arthritis and dia-
betes mellitus [6]. Family history of aggressive periodontitis
is not uncommon and siblings of affected probands show
an increased risk of the disease [7]. Therefore, inheritedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ute to the pathogenesis of the disease.
Reports regarding genetic polymorphisms associated
with periodontitis are increasing and several studies have
shown that different cytokines are involved in periodon-
titis. For instance, single nucletotide gene polymor-
phisms (SNPs) of interleukin (IL-) 1α, IL-1ß, IL-4, IL-6,
IL-8 and IL-18 located in different regions of the men-
tioned cytokine genes have been shown to affect the risk
of the disease in several populations [8-12]. However,
conflicting results regarding the association of SNPs in
several genes with periodontitis are on record [13].
IL-10 SNPs, located both in the promoter or exon re-
gions of the gene, resulted associated with a lower risk
of chronic periodontitis [14].
A strong association between Tumor Necrosis Factor
Alpha (TNF-α) rs1800629 and generalized forms of peri-
odontitis was found [15]. A TNF-α promoter SNP (−308)
has also been associated with the development of the disease
and aggressive periodontitis [16]. However, the association
of IL-10 and TNF-α SNPs with periodontitis in a subse-
quent investigation was not confirmed [17].
It is important to note that genotype prevalence ap-
pears to vary by race and ethnicity of the population
studied. Therefore, the association of SNPs in candidate
genes with modulatory activities on inflammation and
periodontitis remains an open problem.
Highest mean gingival crevicular fluid and serum Vas-
cular Endothelial Growth Factor (VEGF) concentration
increased with the disease severity and reductions in
VEGF levels in both gingival crevicular fluid and serum
samples after periodontitis treatment were reported [18].
Epithelial expression of VEGF A, C, D in gingival was
detected and increased numbers of immune cells ex-
pressing VEGF-C were found after infection, along with
IL-1β and TNF-α protein upregulation [19].
A case–control study to identify the association of
candidate genes epistatic interactions between genetic
risk factors and susceptibility to aggressive periodontitis
by using parametric analysis and higher order inter-
action models [20] has shown that: 1) within 14 candi-
date genes chosen in scientific literatures selenoprotein
S (SEPS1) and tumor necrosis factor receptor superfam-
ily member 1B (TNFRSF1B), have a possible role in de-
termining host individual susceptibility to the disease; 2)
an association between IL-6 and Fc-γ receptor poly-
morphism with periodontitis; 3) no the association of IL-1
cluster gene polymorphism with aggressive periodontitis.
Here, we investigated the genotype and allele distribu-
tion of SNPs in the promoter regions of several genes
with inflammatory modulatory activity such as VEGF,
Alpha-1-Antichymotripsin (ACT), hydroxy-methyl-glutaryl
CoA reductase (HMG-CR), Interferon Gamma (INF-γ),
IL-1ß, IL-10, IL-6, and TNF-α from ethnical homogeneousyoung patients with periodontitis. These genes were se-
lected since their differential but pivotal modulation upon
inflammatory processes. Controls consisted of healthy eld-
erly without history of periodontitis. These SNPs were se-
lected according to our previous investigations showing
that these cytokines were associated with the risk to devel-
oping other chronic and degenerative disease such as acute
myocardial infarction [21] and Alzheimer’s disease [22].
The aim of this study was to investigate the association
of SNPs of several genes with immune regulatory func-
tion with periodontitis. Here we report a genetic signa-
ture that may be used to better assess the risk of the
disease in unaffected subjects.
Results
A panel of 8 SNPs in VEGF, ACT, HMG-CR, INF-γ, IL-1β,
IL-10, IL-6 and TNF-α genes in patients with periodontitis
and controls (CTR) was studied and genotype distributions
and allele frequencies were obtained.
The genotype distribution and allele frequency in the
promoter region of the −2578 C/A SNP in the VEGF
gene are shown in Table 1. The CC genotype was more
frequent in patients affected by periodontitis than CTR
(72.7% vs 33.6%, p = 0.0001; OR = 5.259; ci = 2.956-
9.357). The percentage of VEGF C carriers was signifi-
cantly higher in the patients with periodontitis than
in the CTR (94.8% vs 84.6%, p = 0.021; OR = 3.327;
ci = 1.138-9.726), whereas the percentage of A carriers
was significantly lower in the patients with periodontitis
than CTR (27.3% vs 66.4%, p = 0.0001; OR = 0.190;
ci = 0.107-0.338).
Table 1 also shows genotype distribution and allele fre-
quency of the −1082 G/A SNP in the promoter region
of IL-10 gene. The GG genotype was more frequent in
CTR than in the patients with periodontitis (19.8% vs
9.3%, p = 0.027; OR = 0.412; ci = 0.183-0.926), on the
other hand the AA genotype was more represented in
patients than in CTR (52% vs 35.7%, p = 0.008; OR =
1.929; ci = 1.181-3.151). The G allele was significantly
more frequent in CTR than in patients (64.3% vs 48%,
p = 0.007; OR = 0.513; ci = 0.314-0.839) whereas the
percentage of A carriers was lower in the CTR than in
patients with periodontitis (80.4% vs 90.7%, p = 0.033,
OR = 2.364; ci = 1.051-5.318).
The genotype distribution and allele frequency of
the −308 G/A SNP in the TNF-α gene are shown in
Table 1. The percentage of GG genotype was higher in pa-
tients with periodontitis than CTR (90.7% vs 79.3%, p =
0.025; OR = 2.463, ci = 1.094-5.548); on the other hand, A
carriers were higher among CTR than patients (20.7% vs
9.3%, p = 0.021, OR = 0.395; ci = 0.175-0.889).
The concomitant presence of the C allele of VEGF, the
A allele of IL-10 and the GG genotype of TNF-α was
also determined and resulted to be associated with an
Table 1 VEGF, IL-10 and TNF-α genotype and allele frequency in patients with chronic periodontitis and CTR
VEGF CC CA AA C carriers A carriers
(n) % (n) % (n) % (n) % (n) %
Periodontitis (n = 77) (56) 72.7 (17) 22.1 (4) 5.2 (73) 94.8 (21) 27.3
CTR (n = 214) (72) 33.6 (109) 50.9 (33) 15.4 (181) 84.6 (142) 66.4
Periodontitis vs CTR χ2 = 35.210 p = 0.0001;
CC carriers vs non-CC carriers: χ2 = 35.104, p = 0.0001, OR = 5.259, ci = 2.956-9.357;
AA carriers vs non-AA carriers: χ2 = 5.335, p = 0.021, OR = 0.301, ci = 0.103-0.879;
C carriers χ2 = 5.335, p = 0.021; OR = 3.327; ci = 1.138-9.726;
A carriers χ2 = 35.104, p = 0.0001; OR = 0.190, ci = 0.107-0.338.
IL-10 GG GA AA G carriers A carriers
(n) % (n) % (n) % (n) % (n) %
Periodontitis (n = 75) (7) 9.3 (29) 38.7 (39) 52 (36) 48 (68) 90.7
CTR (n = 470) (93) 19.8 (209) 44.5 (168) 35.7 (302) 64.3 (378) 80.4
Periodontitis vs CTR χ2 = 8.850, p = 0.012;
GG carriers vs non-GG carriers: χ2 = 4.870, p = 0.027, OR = 0.412, ci = 0.183-0.926;
AA carriers vs non-AA carriers: χ2 = 7.054, p = 0.008, OR = 1.929, ci = 1.181-3.151;
A carriers χ2 = 4.563, p = 0.033; OR = 2.364, ci = 1.051-5.318;
G carriers χ2 = 7.255, p = 0.007; OR = 0.513, ci = 0.314-0.839.
TNF-α GG GA AA G carriers A carriers
(n) % (n) % (n) % (n) % (n) %
Periodontitis (n = 75) (68) 90.7 (7) 9.3 (0) 0 (75) 100 (7) 9.3
CTR (n = 440) (349) 79.3 (87) 19.8 (4) 0.9 (436) 99.1 (91) 20.7
Periodontitis vs CTR χ2 = 5.527, p = 0.063.
GG carriers vs non-GG carriers: χ2 = 5.014, p = 0.025; OR = 2.463, ci = 1.094-5.548;
AA vs non-AA carriers: χ2 = 0.861, p = 0.650.
A carriers χ2 = 5.356, p = 0.021, OR = 0.395, ci = 0.175-0.889.
G carriers χ2 = 0.687, p = 0.407.
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genetic signature of these “triple SNP carriers” was more
frequent in the patients with periodontitis than in the
CTR (79.7% vs 34.8%), and the difference was highly sta-
tistically significant (X2 = 47.780, p = 0.0001, OR = 7.375;
ci = 3.973-13.689). An increased frequency of the triple
SNP carriers was also present in the subgroup of patients
with chronic generalized periodontitis (χ2 = 37.745, p =
0.0001, OR = 7.031, ci = 3.551-13.924), as shown in Table 3.Table 2 Concomitant presence of the triple genotype/
allele signature in CTR and all patients with chronic
periodontitis
Triple genotype Carriers Non-carriers
(n) % (n) %
Periodontitis (n = 74) (59) 79.7 (15) 20.3
CTR (n = 276) (96) 34.8 (180) 65.2
Periodontitis vs CTR χ2 = 47.780, p = 0.0001, OR = 7.375,
ci = 3.973-13.689.The SNPs in the promoter regions of the ACT, HMG-
CR, INF-γ, IL-1β and IL-6 genes were also investigated,
but no statistically significant difference in allele and
genotype frequencies between CTR and patients with
periodontitis was found (Table 4).
Discussion
Periodontitis are infectious diseases in which bacteria
and other pathogens trigger chronic inflammatory andTable 3 Concomitant presence of the triple genotype/
allele signature in CTR and patients with chronic
generalized periodontitis
Triple genotype Carriers Non-carriers
(n) % (n) %
Generalized Periodontitis (n = 57) (45) 78.9 (12) 21.1
CTR (n = 276) (96) 34.8 (180) 65.2
Generalized Periodontitis vs CTR χ2 = 37.745, p = 0.0001, OR = 7.031,
ci = 3.551-13.924.
Table 4 ACT, HMC-CR, INF-γ, IL-1β, IL-6 genotype /allele
frequencies in patients with chronic periodontitis and CTR
ACT GG* GT TT G carr T carr
Periodontitis (18) (26) (11) (44) (37)
(n = 55) 32.7 47.3 20 80.0 67.3
CTR (108) (222) (122) (330) (344)
(n = 452) 23.9 49.1 27.0 73 76.1
X2 = 2.487 p = 0.288
X2 = 1.238 p = 0.266 Allele G
X2 = 2.049 p = 0.152 Allele T
* wild type genotype
HMG-CR CC* CA AA C carr A carr
periodontitis (56) (8) (2) (64) (10)
84.8 12.1 3 97 15.2(n = 66)
CTR (349) (63) (7) (412) (70)
(n = 419) 83.3 15 1.7 98.3 16.7
X2 = 0.915 p = 0.633
X2 = 0.579 p = 0.447 Allele C
X2 = 0.100 p = 0.752 Allele A
* wild type genotype
IL-1β CC* CT TT C carr T carr
periodontitis (34) (29) (8) (63) (37)
(n = 71) 47.9 40.8 11.3 88.7 52.1
CTR (142) (129) (35) (271) (166)
(n = 306) 46.4 42.2 11.4 88.6 54.2
X2 = 0.052 p = 0.974
X2 = 0.002 p = 0.968 Allele C
X2 = 0.106 p = 0.745 Allele T
* wild type genotype
INF-γ TT* TA AA T carr A carr
periodontitis (16) (38) (14) (53) (52)
(n = 68) 23.5 55.9 20.6 79.1 77.6
CTR (73) (102) (67) (174) (170)
(n = 242) 30.2 42.1 27.7 71.9 70.2
X2 = 4.055 p = 0.132
X2 = 1.397 p = 0.237 Allele T
X2 = 1.407 p = 0.236 Allele A
* wild type genotype
IL-6 GG* GC CC G carr C carr
periodontitis (40) (25) (12) (64) (36)
(n = 77) 51.9 32.5 15.6 84.2 47.4
CTR (119) (125) (34) (244) (159)
57.2
(n = 278) 42.8 45 12.2 87.8
X2 = 2.329 p = 0.127
X2 = 0.669 p = 0.413 Allele G; X2 = 2.666 p = 0.103 Allele C
* wild type genotype
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flammatory mediators that lead to tissue destruction [1].
Aging is associated with hystological and clinical alter-
ations in oral tissues. For instance, epithelium thinning
and diminished keratinization occur in aged gingival and
cellular components of gingival connective tissue de-
crease with age. These functional and structural alter-
ations in gingival tissues along with a decline of the
immune responses may result in an increased suscepti-
bility of the elderly to microbial infections [4].
The gingival fibroblasts being constantly affected by
the oral bacteria and their products like lipopolysacchar-
ide, release inflammatory cytokines like prostaglandin
E2, interleukin (IL)-1-β, and plasminogen activator [3,4]
and these pro-inflammatory compound and cytokines
may contribute to periodontal destruction [23,24].
Periodontitis is a complex, multifactorial and partially
genetically determined disease and genes of the inflam-
matory response may modulate the periodontitis clinical
expression [1]. Environmental risk factors by interacting
with host genes play an important role in regulating the
inflammatory response [1].
It is interesting to note, that genome wide association
(GWA) studies have shown an association of genetic loci
located in chromosome 9 and 19 with severe chronic
periodontitis [25]. Another GWA investigation reported
that glycolyl-trasferase gene (GLT6D1) was a susceptibil-
ity locus for the disease [26].
Here, SNPs in genes with regulatory effects on inflam-
matory responses as possible genetic markers of periodon-
titis have been investigated. We selected ACT, HMG-CR,
INF-γ, IL-1β, IL-6, VEGF, IL-10 and TNF-α genes, since
they have relevant and differential role in regulating im-
mune responses and have been found to affect the risk of
other chronic diseases where immune alterations were
linked to pathogenetic mechanisms [21,22,27].
SNPs in the promoter region of these genes have been
selected, since variations in this region affect the synthe-
sis of the cognate molecule [21,22].
Some studies have shown that high gingival crevicular
fluid and serum levels of VEGF were associated with the
severity of periodontitis [18]. However, as far as we
know no data regarding SNP distribution in the pro-
moter region of VEGF in patients affected by periodon-
titis have been reported. Our findings show that the CC
genotype and the C allele of VEGF are more frequent in
the patients with periodontitis than in CTR and result as
genetic risk factors for the disease. Our findings suggest
that homozygous subjects (CC) show a slightly higher
risk of the disease than heterozygous (OR = 5.259 and
OR = 3.327, respectively).
Lymphangiogenesis, the formation of new lymphatics,
is associated with chronic inflammation and tissue in-
jury; its role being to enhance lymphatic flow, immune
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lymphatic vessels occurs during development of peri-
odontitis and the upregulation of VEGF is likely to be
important for the growth of lymphatic vessels [19].
VEGF expression is a key regulator of physiologic and
pathologic angiogenesis and subjects with the CC geno-
type or the C allele may be prone to aberrant angiogen-
esis and lymphangiogenesis that in turn may predispose
to the periodontitis.
Our data show that the A allele of IL-10 is more fre-
quent in patients with periodontitis than in CTR and is
a genetic risk factor for the disease (OR = 2.364). IL-10
polymorphism has been associated with chronic peri-
odontitis and our data are in accordance with other in-
vestigations showing that SNPs in the IL-10 gene are
associated with an increased risk and progression of
periodontitis [28]. These findings support the notion
that subjects with defective IL-10 production (A carriers)
are prone to develop chronic inflammation and peri-
odontitis. In fact, IL-10, an anti-inflammatory cytokine,
seems to attenuate periodontal tissue destruction through
the induction of tissue inhibitors of metalloproteinases
and osteoprotegerin, an inhibitor of osteoclastogenesis
[29]. Our findings are also in agreement with a recent re-
port showing an IL-10 SNP association with chronic and
aggressive periodontitis [30].
However, other studies did not support a role of IL-10
SNP in periodontitis [17]. These discrepancies may be
attributed to different selection criteria of patients and
controls or their ethnic heterogeneity.
Our findings also show that the GG genotype of TNF-
α is a genetic risk factor for periodontitis (OR = 2.463).
Present data regarding TNF-α SNP association with
periodontitis are in accordance with other case-controls
investigations [15,16] and support a role for TNF-α in
chronic inflammation and bone remodeling, as shown
for different diseases such as rheumatoid arthritis [31].
Other studies, however, were not able to confirm any
association of TNF-α SNPs with the disease [32,33].
Once again, patient/control selection criteria and/or eth-
nic heterogeneity may explain conflicting results. On the
other hand the above factors (selection criteria, ethni-
city) along with the severity of the disease may partially
explain why we were not able to find any association of
periodontitis with other SNPs such as INF-γ, IL-1β, IL-6.
Our findings are in fact at variance with other investiga-
tions showing that gene variations of INF-γ, IL-1β and
IL-6 were associated with periodontitis [8,10,16].
The concomitant presence of C allele of the VEGF
gene, the A allele of the IL-10 gene and the G allele of
the TNF-α gene (“triple SNP signature”) is highly in-
creased in patients with periodontitis (OR = 7.375). This
triple SNP signature is also over-represented in the
group of patients with generalized periodontitis.The age difference between control and patients with
periodontitis was relevant; however, such a difference
could not influence the genetic inheritance of SNPs in
genes with immune regulatory functions and the aim of
this investigation was to find possible differential distri-
bution in some SNPs of these genes. Moreover, drug-
abuse and different life styles between patients and CTR
may differentially affect susceptibility to periodontitis
but, it is unlikely that these factors may influence the
genetic background associated with the risk of the
disease.
Conclusions
Periodontitis is influenced by environmental, metabolic,
microbial, poor oral hygiene status and life-style habits,
as well as aging.
In this pilot study young patients with an increased
susceptibility to develop periodontitis because of their
former drug-use and life-style were selected to search
for candidate genes associated with the disease. CTR
group consisted of healthy elderly without history of
clinical periodontitis and other inflammatory diseases.
These differences between cases and CTR may increase
the probability to find SNP associated with the disease.
On the other hand, drug-abuse and different life styles
between patients and CTR indeed differentially affect
susceptibility to periodontitis, however it is unlikely that
these factors may influence the genetic background asso-
ciated with the risk of the disease.
SNPs in genes with regulatory immune function were
selected. The C allele of VEGF, a regulator gene of
angiogenesis and lymphangiogenesis, the A allele of IL-10,
an anti-inflammatory gene and the GG genotype of TNF,
a gene involved in both inflammation and bone remodel-
ing, were associated with an increased risk of periodontal
disease. Moreover the concomitant presence of these
three genetic markers highly increased the risk of the dis-
ease. Therefore, these three genes appear to play a syner-
gistic role in the development of chronic periodontitis.
The concomitant presence of these different genetic
markers may be used to identify among unaffected sub-
jects with positive familial history of chronic periodontitis
those with elevated risk of developing the disease and,
therefore, be used to implement periodontitis prevention
or early intervention screenings. However it is important
to stress that these preliminary data need to be confirmed
in larger case/control investigations to further assess their
role in this disease.
Methods
Patients and controls
The study involved 77 patients with periodontitis (mean
age 30 ± 6 years, 60 male and 17 female) from “San
Patrignano Community”, a private residential community
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Italy. Patients suffered chronic periodontitis: 58 patients
were affected by chronic generalized periodontitis and 19
patients by chronic localised periodontitis. The drugs
users are usually at increased risk of developing periodon-
titis. Therefore, these subjects, because of their increased
susceptibility to the disease may provide a good model to
investigate candidate genes associated with the periodon-
tal disease.
Clinical examination was performed by two dentists and
the clinical diagnosis of chronic periodontitis followed cri-
teria of the 1999 Consensus Classification of Periodontal
Diseases [33]. Each patient was also investigated by oral
radiograms. Chronic generalized periodontitis was diag-
nosed when more than 30% of periodontal sites was af-
fected and chronic localized periodontitis when less than
30% of periodontal sites was involved. Exclusion criteria
included history or current manifestation of systemic dis-
eases such as diabetes, cardiovascular diseases, hepatitis,
HIV infection and autoimmunity, use of antiseptic and
anti-inflammatory drugs for a period longer than a week
during the three months preceding the enrolment and
smoking (no smoking during at least one year preceding
the enrolment).
The control population belonged to the Conselice
Study of Brain Aging from Northern Italy [21] and in-
cluded 452 healthy subjects (mean age 72 ± 6 years, 235
male and 289 female) with no history of periodontitis
and systemic diseases such as diabetes, cardiovascular
diseases, hepatitis, HIV infection, autoimmunity or other
inflammatory diseases before and during a 5 years fol-
low up.
This elderly control population was selected to minimize
the presence of subclinical periodontal alterations in our
controls. Both periodontitis patients and controls were eth-
nically homogenous, since they were caucasian and from a
restricted region of northern Italy written consent forms
for genetic tests from each patient and control were
collected. CTR and patients with periodontitis showed
a significant age difference , however, controls have
been selected according their negative anamnestic re-
cords of clinical peroidontitis with the aim to minimize
the presence of the disease during their life. Moreover,
such an age difference could not influence the genetic
inheritance of SNPs in the gene with immune regula-
tory functions.
Moreover, drug-abuse and different life styles between
patients and CTR may differentially affect susceptibility
to periodontitis, however it is unlikely that these factors
may influence the genetic background associated with
the risk of the disease.
For the reduced number of case this study case–con-
trol it should be considered a “pilot study” to extend in
a future at a large number of patients.The research protocol was approved by the ethical com-
mittee of San Patrignano Community, Coriano, Rimini,
Italy.
DNA extraction
Epithelial cells samples from the oral cavity were col-
lected by buccal swabs (Epicentre Biothechnologies,
Italy). DNA extraction from swab was performed adding
600 μl of 50 mM NaOH to brush and heating at 95°C
for 5 minutes. After brush removal, 60 μl of 1 M Tris
pH 8 were added. Genome DNA was obtained spinning
the sample at 13.000 rpm for 1 minute.
DNA CTR samples were obtained from peripheral
blood leukocytes, as previously described [27].
Though DNA samples from periodontitis patients
were obtained by buccal swabs while those from CTR
were obtained from peripheral blood leukocytes, the dif-
ference in DNA sources does not have any relevance as
far as SNP genotype is concerned, since genotype varia-
tions are equally distributed in all nucleated cells.
SNP Detection
The presence of SNPs in the promoter regions of the
VEGF (−2578 C/A, rs699947), ACT (−51 G/T, rs1884082),
HMG-CR genes (−911 C/A, rs3761740) and IL-6 (−174 G/C,
rs1800795) was assessed by polymerase chain reaction
(PCR)-based methods as previously described [27,34-36].
SNPs in the IL-1β (−511 C/T, rs16944), IL-10 (−1082 G/A,
rs1800896), IFN-γ (+874 T/A, rs2430561) and TNF-α
(−308 G/A, rs1800629) genes were detected by real-time
PCR. The SNP-specific primers and probes were designed
using the TaqMan genotyping assay (ABI, Foster City, CA)
in a 25 μl total volume of BIORAD CFX 96 in accordance
with the manufacturer’s instructions [21].
The present investigation was a double bind study,
since operators did not know the diagnosis of each
subject.
Statistical analysis
The genotype distribution and allele frequency from
CTR and periodontitis patients were compared by con-
tingency tables and chi square (χ2) analysis. Odds ratio
(OR) and confidence intervals (c.i.) were also calculated
and statistical significance assessed by using the SPSS
11.01 software package (SPSS Inc, Chicago IL, USA).
Statistical tests were two-sided, and significance was set
at p <0.05. Bonferroni’s correction for multiple compari-
sons was also used.
Abbreviation
(SNPs): Single nucletotide gene polymorphisms; (IL-): Interleukin;
(TNF-α): Tumor Necrosis Factor Alpha; (VEGF): Vascular endothelial growth
factor; (ACT): Alpha-1-Antichymotripsin; (HMG-CR): Hydroxy-methyl-glutaryl CoA
reductase; (INF-γ): Interferon Gamma; (CTR): Controls; (GWA): Genome wide
association. The concomitant presence of C allele of the VEGF gene, the A allele
of the IL-10 gene and the G allele of the TNF-α gene (“triple SNP signature”).
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